Interesting, biotech stocks have been notoriously hard to predict because their business model revolves around science, and it’s hard to know when the science is right. Depending on the situation, I think sentiment could potentially be a misleading/confounding variable here…

Sentiment is crucial - if you know sentiment is incorrectly oriented, you can capitalize on it. If you know it's correct, you can identify mispricing, and strategize accordingly.